Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The relationship between ECG predictors of cardiac resynchronization therapy benefit

J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,

. 2019 ; 14 (5) : e0217097. [pub] 20190531

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006303
003      
CZ-PrNML
005      
20200518132528.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0217097 $2 doi
035    __
$a (PubMed)31150418
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Halamek, Josef $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
245    14
$a The relationship between ECG predictors of cardiac resynchronization therapy benefit / $c J. Halamek, P. Leinveber, I. Viscor, R. Smisek, F. Plesinger, V. Vondra, J. Lipoldova, M. Matejkova, P. Jurak,
520    9_
$a INTRODUCTION: Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. METHODS & RESULTS: SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects- 295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. CONCLUSION: SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too "strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.
650    _2
$a akční potenciály $7 D000200
650    _2
$a blokáda Tawarova raménka $x patofyziologie $x terapie $7 D002037
650    _2
$a srdeční resynchronizační terapie $x metody $7 D058406
650    _2
$a prostředky srdeční resynchronizační terapie $x normy $7 D058409
650    _2
$a elektrická defibrilace $7 D004554
650    _2
$a elektrokardiografie $x metody $x normy $7 D004562
650    _2
$a srdeční frekvence $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a výsledek terapie $7 D016896
650    _2
$a funkce levé komory srdeční $7 D016277
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Leinveber, Pavel $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Viscor, Ivo $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Smisek, Radovan $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Plesinger, Filip $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Vondra, Vlastimil $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
700    1_
$a Lipoldova, Jolana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Matejkova, Magdalena $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Jurak, Pavel $u Institute of Scientific Instruments of the Czech Academy of Sciences, Brno, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 5 (2019), s. e0217097
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31150418 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132527 $b ABA008
999    __
$a ok $b bmc $g 1525161 $s 1096359
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 5 $d e0217097 $e 20190531 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20200511

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...